The membership will give the Nencki Institute of Experimental Biology PAS the opportunity to co-design future iterations of EBRAINS’ cutting-edge tools and services. These state-of-the-art capabilities - which include an extensive range of brain data sets, a multilevel brain atlas, modelling and simulation tools, and access to high-performance computing resources and robotics and neuromorphic platforms - aim to help European researchers to address major challenges in brain health.
The Nencki Institute is one of the leading non-university biomedical research centers in Poland. Its mainstream research focuses on new therapies and diagnostic methods for metabolic disorders, neurodegenerative diseases, neurological disorders, cancer, diabetes and other civilization diseases. The mission of the Nencki Institute is to conduct studies that can be directly translated to health protection and improving quality of life. Research in neuroscience, including neuroanatomy, neurochemistry, neurophysiology, and psychology, has been conducted at the Nencki Institute for over a century. The Institute combines the latest technological advances with sophisticated imaging, molecular biology and advanced bioinformatics tools to implement ambitious, interdisciplinary research projects.
The EBRAINS research infrastructure, a key outcome and legacy of the EU-funded Human Brain Project (HBP), was officially launched in 2019. Two years later, in 2021, EBRAINS was included in the Roadmap of the European Strategy Forum on Research Infrastructures (ESFRI). In this next phase, after the recent conclusion of the HBP, EBRAINS will complete the transition into a sustainable infrastructure.
EBRAINS is an open research infrastructure that gathers high-quality research data, tools and computing facilities for brain-related research, built with interoperability at the core. The infrastructure offers an extensive range of brain data sets, a multilevel brain atlas, modelling and simulation tools, and access to high-performance computing resources and robotics and neuromorphic platforms to researchers. Explore the tools and services available here.
News & eventsAll news & events
- Press release20 Feb 2024
- Press release09 Jan 2024